Email updates

Keep up to date with the latest news and content from BMC Pharmacology and Toxicology and BioMed Central.

Open Access Highly Accessed Email this article to a friend

A review of the differences and similarities between generic drugs and their originator counterparts, including economic benefits associated with usage of generic medicines, using Ireland as a case study

Suzanne Dunne*, Bill Shannon, Colum Dunne and Walter Cullen

BMC Pharmacology and Toxicology 2013, 14:1  doi:10.1186/2050-6511-14-1

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.
How can I ensure that I receive BMC Pharmacology and Toxicology's emails?